Previous 10 | Next 10 |
Summary Repositioning cross-asset and equity-focused portfolios has been a challenging affair in the latter half of FY22. Such has been the case for longs of MD, where the investment debate how now is negatively skewed to the downside. MD is faced with a series of hurdles to ramp up...
Shares of R1 RCM (NASDAQ: RCM) rose 10% on Tuesday. The stock closed at $7.51 on Monday, then opened on Tuesday at $7.52. It rose to a daily high of $8.31 shortly after 2 p.m. ET before closing at $8.25. The stock has a 52-week low of $6.71 and a 52-week high of $27.86 and is down m...
SAN FRANCISCO, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges R1 RCM Inc. (NASDAQ: RCM) investors who suffered significant losses to submit your losses now . Visit: https://www.hbsslaw.com/investor-fraud/RCM Contact An Attorney Now: RCM@hbsslaw.com ...
SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP ( www.JohnsonFistel.com ) is investigating whether R1 RCM Inc. (NASDAQ: RCM), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclo...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/Anastasia Zagoruyko Some healthcare market investors are probably feeling ill today, as financial traders are dumping R1 RCM (NASDAQ: RCM ) stock like there’s no tomorrow. What are th...
The following slide deck was published by R1 RCM Inc. in conjunction with their 2022 Q3 earnings call. For further details see: R1 RCM Inc. 2022 Q3 - Results - Earnings Call Presentation
R1 RCM Inc. (RCM) Q3 2022 Earnings Conference Call November 8, 2022 8:30 A.M. ET Company Participants Atif Rahim - Head, Investor Relations Joe Flanagan - Chief Executive Officer Lee Rivas - President Rachel Wilson - Executive Vice President, Chief Finance Of...
Technology-driven solutions provider R1 RCM ( NASDAQ: RCM ) appointed President Lee Rivas to succeed Joseph Flanagan as CEO, effective Jan. 1, 2023. Rivas will also join the company's board. Flanagan will leave the position from the same date, but will continue to...
R1 RCM ( NASDAQ: RCM ) is trading 39% lower premarket after the company posted lower-than-expected Q3 result and appointed Lee Rivas to succeed Joseph Flanagan as chief executive officer, effective Jan. 1. Revenue rose 30.6% Y/Y to $ $496M, but missed...
R1 RCM press release ( NASDAQ: RCM ): Q3 GAAP EPS of -$0.07 misses by $0.19 . Revenue of $496M (+30.6% Y/Y) misses by $27.69M . For 2022, R1 now expects to generate:-Revenue of between $1,790 million and $1,800 milliovs $1.87B Consensus GAAP operating...
News, Short Squeeze, Breakout and More Instantly...
MURRAY, Utah, July 24, 2024 (GLOBE NEWSWIRE) -- The Special Committee of the R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”) Board of Directors, which comprises independent directors and was formed to evaluate strategic alternatives in response to the Schedule 13D/A ...
MURRAY, Utah, July 15, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months ended ...
2024-07-09 09:00:05 ET George Hill from Deutsche Bank issued a price target of $16.00 for RCM on 2024-07-09 07:36:00. The adjusted price target was set to $16.00. At the time of the announcement, RCM was trading at $12.66. The overall price target consensus is at $19.00 ...